Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection

Pediatric Infectious Disease Journal

Volumn 21, Issue 2, 2002, Pages 119-125

  Yogev, Ram ^a   Lee, Sophia ^b   Wiznia, Andrew ^e   Nachman, Sharon ^f   Stanley, Kenneth ^b   Pelton, Stephen ^c   Mofenson, Lynne ^g   Fiscus, Susan ⁱ   Jimenez, Eleanor ^j   Rathore, Mobeen H ^k   Smith, Mary Elizabeth ^h   Song, Lin Ye ^b   Mcintosh, Kenneth ^d  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e JACOBI MEDICAL CENTER   (United States)

^f STONY BROOK UNIVERSITY   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j San Juan City Hospital   (Puerto Rico)

^k UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

more..

Author keywords

Children; Human immunodeficiency virus; Lamivudine; Nevirapine; Nucleoside analogue reverse transcriptase inhibitor; Protease inhibitor; Ritonavir; Stavudine; Zidovudine

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADOLESCENT; ANTIBIOTIC THERAPY; ANTIVIRAL ACTIVITY; ARTICLE; CHILD; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIRUS LOAD;

ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INFANT; MALE; NEVIRAPINE; RNA, VIRAL; STAVUDINE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0036168689     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200202000-00007     Document Type: Article

References (27)

1. Prevention Guidelines for the use of antiretroviral agents in pediatric HIV infection
2. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
3. Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: A randomized controlled study
4. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent and long-term mortality risk in HIV-1 infected children
5. + lymphocytes as prognostic markers of HIV-1 infection
6. Revised classification system for HIV infection in children <13 years of age
7. Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: A report based on 2 years of the NIAID DIADS flow cytometry quality assessment program
8. Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma
9. Evaluation of the ultrasensitive Roche Amplicor HIV-1 monitor assay for quantitation of human immunodeficiency virus type 1 RNA
10. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories
11. Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: Effect of an external standard in kit comparisons
12. Exact significance testing for ordered categorical data
13. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
14. Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection
15. A one year experience: T cell responses and viral replication in children with advanced human immunodeficiency virus type 1 disease treated with combination therapy including ritonavir
16. Clinical, virologic and immunologic responses on children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors
17. + lymphocyte count in HIV-infected infants and children
18. Viral load and disease progression in infants infected with human immunodeficiency virus type 1
19. Age-and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus
20. Abnormal body-fat distribution in HIV-1-infected children on antiretrovirals
21. Drug compliance in pediatrics clinical and research issues
22. Adherence, compliance, and HAART
23. Stavudine plus lamivudine in advanced human immunodeficiency virus disease: A short-term pilot study
24. A randomized study of combined zidovudine-lamivudine vs. didanosine monotherapy in children with symptomatic therapy-naïve HIV-1 infection